Status:
COMPLETED
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
Lead Sponsor:
Barretos Cancer Hospital
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aims to compare in a prospective and randomized way actinic keratosis treatment with 5-aminolevulinic acid photodynamic therapy versus cryotherapy, from the standpoint of therapeutic effica...
Detailed Description
Actinic keratosis is a skin lesion induced by chronic sun exposure with a significant prevalence and malignant potential for squamous cell carcinoma, which makes essential its treatment. Today there a...
Eligibility Criteria
Inclusion
- Patients older than 18 years.
- Patients with actinic keratoses "symmetrical", ie, comparable in the upper limbs ( with the same grade, I, II or III).
- Patients in accordance with informed consent.
Exclusion
- Patients with concomitant skin diseases, congenital or acquired (albinism, vitiligo, xeroderma, Gorlin, etc.)
- Immunosuppression (HIV, transplanted patients, etc.)
- Pregnancy or lactation
- Patients who do not agree with the informed consent initially or during the protocol.
- Presence of pigmented lesions near the keratoses.
- Patients with porphyria.
- Patients who have undergone less than 2 months with some kind of treatment for keratosis in the upper limbs.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT01459393
Start Date
November 1 2010
End Date
November 1 2011
Last Update
June 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barretos Cancer Hospital
Barretos, São Paulo, Brazil, 14.784 - 400